companydata.dkVesper Bio ApS: Financial statements 2018
CVR: 32879861
Vesper Bio ApS (CVR 32879861) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -3,992,474 compared with DKK -2,680,191 the year before. Equity amounted to DKK 3,893,057. The solvency ratio was 76.1%. The company had 1 employee in the financial year.
- Profit/Loss
- -3,992,474 kr.
- Equity
- 3,893,057 kr.
- Total Assets
- 5,113,760 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -4 mio. | 3.9 mio. | 1 |
| 2017 | - | - | -2.7 mio. | 7.9 mio. | 0 |
| 2016 | - | - | -4 mio. | 3.1 mio. | - |
| 2015 | - | - | -6.1 mio. | 7.1 mio. | - |
| 2014 | - | - | -6.9 mio. | 5.6 mio. | - |
Keep an eye on Vesper Bio ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
As of October 1, 2018, Paul Brian Little is registered as adm. dir. of Vesper Bio ApS.
As of September 30, 2018, Christian Ellebæk Elling has stepped down as adm. dir. of Vesper Bio ApS.
Vesper Bio ApS has published its annual report for 2017. The net result was DKK -2,680,191.
About Vesper Bio ApS
Vesper Bio ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2010. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named INSUSENSE ApS. The management consists of Jacob Falck Hansen. The company is owned by 75PMK Holding ApS and LUNDBECKFONDEN. The company has 3 employees. In 2025, the company reported a gross profit of DKK -36,446,130 and a net result of DKK -48,200,991 compared with DKK -66,506,349 the year before. Equity amounted to DKK -227,433,239.